A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · NONE
- Evidence population
- Human clinical study registration
- Participants
- 126
- Population
- FEMALE · 18 Years
- Duration
- 2026-02-01 to 2029-02-28
- Intervention
- Pre-habilitation exercise program
- Comparator
- Lifestyle counseling
- Outcomes measured
- Exercise capacity — Baseline and 6 months; Pathologic Complete Response (pCR) — At surgery, following completion of neoadjuvant treatment; Residual Cancer Burden (RCB) — At surgery, following completion of neoadjuvant treatment; Stromal Tumor-Infiltrating Lymphocytes (sTILs) — Baseline diagnostic biopsy and surgery; Tumor Angiogenesis — Baseline diagnostic biopsy and surgery; Tumor tissue Insulin-like growth factor 1 (IGF-1) expression — Baseline diagnostic biopsy and surgery; IGF-1 receptor expression (IGF-1R) — Baseline diagnostic biopsy and surgery; Ki-67 expression — Baseline diagnostic biopsy and surgery; Lipid Profile — Baseline and 6 months; Blood glucose — Baseline and 6 months; Glycated hemoglobin (HbA1c) — Baseline and 6 months; Insulin — Baseline and 6 months; Liver function markers — Baseline and 6 months; C-reactive protein (CRP) — Baseline and 6 months; High-sensitivity C-reactive protein (hs-CRP) — Baseline and 6 months; Interleukin-6 (IL-6) — Baseline and 6 months; Neutrophil-to-lymphocyte ratio (N/L) — Baseline and 6 months; Platelet-to-lymphocyte ratio (P/L) — Baseline and 6 months; Thyroid Function — Baseline and 6 months; Epigenetic markers — Baseline and post-intervention/pre-surgery
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Cancer and ageing · 100%Title contains controlled term: cancer. Abstract contains controlled term: cancer, tumor. Source terminology contains: cancer. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.
- Chronic inflammation · 80%Title contains controlled term: chronic inflammation. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.
- Exercise · 100%Title contains controlled term: physical activity. Abstract contains controlled term: exercise. Source terminology contains: exercise. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.